HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zong, C. S. Articles by Wang, L.-H. Search for Related Content PubMed PubMed Citation Articles by Zong, C. S. Articles by Wang, L.-H. Social Bookmarking                      What's this?

Volume 272, Number 3, Issue of January 17, 1997 pp. 1500-1506
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Mutations of Ros Differentially Effecting Signal Transduction Pathways Leading to Cell Growth Versus Transformation

(Received for publication, July 31, 1996, and in revised form, October 15, 1996)

From the Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029

The signaling functions of the oncogenic protein-tyrosine kinase v-Ros were studied by systematically mutating the tyrosine residues in its cytoplasmic domain. The carboxyl mutation of Tyr-564 produces the most pronounced inhibitory effect on v-Ros autophosphorylation and interaction with phospholipase C. A cluster of 3 tyrosine residues, Tyr-414, Tyr-418, and Tyr-419, within the PTK domain of v-Ros plays an important role in modulating its kinase activity. The mutant F419 and the mutant DI, deleting 6-amino acids near the catalytic loop, retain wild type protein tyrosine kinase and mitogenic activities, but have dramatically reduced oncogenicity. Both mutant proteins are able to phosphorylate or activate components in the Ras/microtubule-associated protein kinase signaling pathway. However, F419 mutant protein is unable to phosphorylate insulin receptor substrate 1 (IRS-1) or promote association of IRS-1 with phosphatidylinositol 3-kinase. This tyrosine residue in the context of the NDYY motif may define a novel recognition site for IRS-1. Both F419 and DI mutants display impaired ability to induce tyrosine phosphorylation of a series of cytoskeletal and cell-cell interacting proteins. Thus the F419 and DI mutations define v-Ros sequences important for cytoskeleton signaling, the impairment of which correlates with the reduced cell transforming ability.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y. Yamada, N. Metoki, H. Yoshida, K. Satoh, K. Kato, T. Hibino, K. Yokoi, S. Watanabe, S. Ichihara, Y. Aoyagi, et al. Genetic Factors for Ischemic and Hemorrhagic Stroke in Japanese Individuals Stroke, August 1, 2008; 39(8): 2211 - 2218. [Abstract] [Full Text] [PDF]

				S. Uttamsingh, C. S. Zong, and L.-H. Wang Matrix-independent Activation of Phosphatidylinositol 3-Kinase, Stat3, and Cyclin A-associated Cdk2 Is Essential for Anchorage-independent Growth of v-Ros-transformed Chicken Embryo Fibroblasts J. Biol. Chem., May 23, 2003; 278(21): 18798 - 18810. [Abstract] [Full Text] [PDF]

				U. Hermanto, C. S. Zong, W. Li, and L.-H. Wang RACK1, an Insulin-Like Growth Factor I (IGF-I) Receptor-Interacting Protein, Modulates IGF-I-Dependent Integrin Signaling and Promotes Cell Spreading and Contact with Extracellular Matrix Mol. Cell. Biol., April 1, 2002; 22(7): 2345 - 2365. [Abstract] [Full Text] [PDF]

				K. T. Nguyen, C. S. Zong, S. Uttamsingh, P. Sachdev, M. Bhanot, M.-T. Le, J. L.-K. Chan, and L.-H. Wang The Role of Phosphatidylinositol 3-Kinase, Rho Family GTPases, and STAT3 in Ros-induced Cell Transformation J. Biol. Chem., March 22, 2002; 277(13): 11107 - 11115. [Abstract] [Full Text] [PDF]

				H. R. Bose Jr. Interferon Regulatory Factor 4 Contributes to Transformation of v-Rel-Expressing Fibroblasts Mol. Cell. Biol., October 1, 2001; 21(19): 6369 - 6386. [Abstract] [Full Text] [PDF]

				C. S. Zong, L. Zeng, Y. Jiang, H. B. Sadowski, and L.-H. Wang Stat3 Plays an Important Role in Oncogenic Ros- and Insulin-like Growth Factor I Receptor-induced Anchorage-independent Growth J. Biol. Chem., October 23, 1998; 273(43): 28065 - 28072. [Abstract] [Full Text] [PDF]

				W. Li, Y.-X. Jiang, J. Zhang, L. Soon, L. Flechner, V. Kapoor, J. H. Pierce, and L.-H. Wang Protein Kinase C-delta Is an Important Signaling Molecule in Insulin-Like Growth Factor I Receptor-Mediated Cell Transformation Mol. Cell. Biol., October 1, 1998; 18(10): 5888 - 5898. [Abstract] [Full Text]